December 9, 2024

Vodafone Group updates on Vodafone UK and Three UK merger

Vodafone and CK Hutchison Group have reached an agreement to merge their UK telecom businesses. Discover non-financial details and transaction updates...

GSK Plc Nucala COPD submission accepted by FDA

GSK announces FDA review of Nucala for COPD treatment following successful MATINEE study data, aiming to be the first approved monthly biologic...

Diploma Plc publishes 2024 Annual Report

Diploma PLC (LON:DPLM) releases its 2024 Annual Report and AGM details, providing key financial insights and shareholder information...

Versarien signs distribution agreement with ABC to market graphene-based biosensors

Versarien Plc launches a groundbreaking biosensor chip featuring advanced graphene barristor technology, set to revolutionize diagnostics in the UK and Europe...

Poolbeg Pharma plc presents POLB 001 pre-clinical study data at the 66th ASH meeting

Poolbeg Pharma unveils promising POLB 001 data at ASH Meeting, highlighting its potential as a CRS preventative therapy in cancer immunotherapies...

Touchstone Exploration reveals 2025 capital budget to boost Cascadura growth

Touchstone Exploration Inc. unveils its 2025 capital budget focusing on sustainable growth by leveraging the success of its Cascadura asset...
Search

Funds

December 17, 2019

Vodafone Group updates on Vodafone UK and Three UK merger

Vodafone and CK Hutchison Group have reached an agreement to merge their UK telecom businesses. Discover non-financial details and transaction updates...

GSK Plc Nucala COPD submission accepted by FDA

GSK announces FDA review of Nucala for COPD treatment following successful MATINEE study data, aiming to be the first approved monthly biologic...

Diploma Plc publishes 2024 Annual Report

Diploma PLC (LON:DPLM) releases its 2024 Annual Report and AGM details, providing key financial insights and shareholder information...

Versarien signs distribution agreement with ABC to market graphene-based biosensors

Versarien Plc launches a groundbreaking biosensor chip featuring advanced graphene barristor technology, set to revolutionize diagnostics in the UK and Europe...

Poolbeg Pharma plc presents POLB 001 pre-clinical study data at the 66th ASH meeting

Poolbeg Pharma unveils promising POLB 001 data at ASH Meeting, highlighting its potential as a CRS preventative therapy in cancer immunotherapies...

Touchstone Exploration reveals 2025 capital budget to boost Cascadura growth

Touchstone Exploration Inc. unveils its 2025 capital budget focusing on sustainable growth by leveraging the success of its Cascadura asset...
Search

Funds

December 9, 2024

FTSE 100

Funds

Day: December 9, 2024